Related by context. Frequent words. (Click for all words.) 55 Q3 Loss Narrows 55 Host Fourth Quarter 55 CEOcast Inc. 54 Q2 Loss Narrows 54 #.#.# #.#.# FAX 54 +#-#-#-# Ext [001] 53 INVESTOR CONTACT 53 Hold Fourth Quarter 53 Updates Guidance 53 CONTACT Investor Relations 53 Q2 Loss Widens 52 Q1 Loss Narrows 52 Stellar Pharmaceuticals 52 -0 CONTACT 52 Guides FY# 52 Reports Profitable 51 Investor Relations Contacts 51 Contacts Investor Relations 51 Record Fourth Quarter 51 Host Third Quarter 51 Record Second Quarter 51 Host Second Quarter 51 Schedules Fiscal 51 Preliminary Fourth Quarter 51 Secures Additional 51 Manitex International 51 Forecast Quick Facts 51 Investor Inquiries 51 ICON plc 51 Revenues Increase 51 Zygo Corporation 50 http:/profnet.prnewswire.com/ud public.jsp?useridShuan 50 Wegener Corporation 50 Q3 Loss Widens 50 Guides Q3 50 Schedules Fourth Quarter 50 Guides Q2 50 BioMarin Genzyme LLC 50 Guides Q4 49 Codon Devices 49 MiMedx Group 49 Inc Therapeutic Competitors 49 Q1 Loss Widens 49 CFO Quick Facts 49 Ligand Pharmaceuticals Incorporated 49 Guides Above 49 Q4 Loss Narrows 49 EVP CFO 49 Reaffirms Guidance 49 Aradigm Corporation 49 ZYGO 49 Guides Below 49 Interim CFO 49 ANTs software 49 Gen Probe Incorporated 49 Above Estimates 49 Named Cool Vendor 49 Anika Therapeutics 49 RF Monolithics Inc. 48 @ mailto 48 http:/profnet.prnewswire.com/Subscriber/ExpertProJim Argue 48 Applied Imaging 48 CEO Exercises Options 48 Lowers Guidance 48 pro forma EPS 48 Schedules Second Quarter 48 Record Third Quarter 48 Raises Guidance 48 Q4 Loss Widens 48 Regains Compliance With 48 +#-#-#-# SOURCE [001] 48 FutureIT 48 Cyntellect 48 Lifts FY# EPS 48 Ocean Bio Chem 48 View Quick Facts 48 CASMED 48 Q2 Profit Surges 48 Guides Q1 47 Genaera Corporation 47 BioElectronics Corporation 47 G. Simmonds 47 WindTamer Corporation 47 CFO Resigns 47 ARIAD Pharmaceuticals Inc. 47 Raises FY# 47 Net Loss Narrows 47 FY# Quick Facts 47 eOn 47 Financial Officer 47 Upcoming Investor Conference 47 MFLEX 47 Director Exercises Options 47 Announces Departure 47 Visualant 47 Earnings Guidance 47 BioSpecifics Technologies Corp. 47 Net Loss Widens 47 Two Investor Conferences 46 Files Annual Report 46 Fiscal Second Quarter